Malaysia gains exclusive rights to Japanese cancer treating vaccine

10 August 2015
Rate this item
(0 votes)

the rakyat post l

KUALA LUMPUR, Aug 10, 2015 -- A private medical centre has been entrusted by a Japanese research centre to expand the use of its Hasumi Immuno-Therapeutic Vaccine (HITV) for the treatment of cancer in Malaysia as well as other overseas markets.

Mahameru International Medical Centre managing director Dr Beh Chor Khim said the firm had been granted exclusive global licensing rights for intellectual property and current and future research as well as development of Hasumi International Research Foundation (HIRF).

He said this in a press statement issued in conjunction with the signing of a joint venture between himself and managing director of HIRF Minoru Komura here last night.

The signing was witnessed by former Prime Minister Tun Dr Mahathir Mohamad.

Dr Beh said through the agreement, Kuala Lumpur would be the first city outside of Japan to have a one-stop Hasumi Immunotherapy centre.

The centre has recorded a high success rate in the treatment of stage four cancer.

It has been reported that the treatment was discovered by Dr Hasumi Kenichiro in 2005. Now known as Hasumi Immuno-Therapeutic Vaccine (HITV), it works by adjusting and upgrading the patient’s own immune system to target cancer cells.

Over 500 patients with late stage cancer treated with HITV in Hasumi’s clinic in Tokyo are said to have shown high complete response and partial response rates.


However, the treatment cannot be considered as a cure as it can only be done if cancerous tumours could be identified. It is meant to complement rather than replace conventional treatment.

MIMC, set up in 2007 for the treatment of ambulatory medical facilities, had teamed up with Dr Hasumi to provide HITV protocol to cancer patients in Malaysia since 2010.

HIRF was founded as a non-profit organisation by Dr Kenichiro Hasumi. It aims to conduct and support scientific research to find a cure for many types of cancers, especially by using immunotherapy.

Link : http://www.therakyatpost.com/news/2015/08/11/malaysia-gains-exclusive-rights-to-japanese-cancer-treating-vaccine/ 

Read 1683 times Last modified on Monday, 17 August 2015 13:02

Our Location

Mahameru International Medical Centre S/B
107 & 109 Jalan Maarof, Bangsar,
59000, Kuala Lumpur

GPS coordinates
3.134 latitude, 101.6727 longtitude
3° 8' 2.4" 101° 40' 31.72"

Contact us

  • Hot line: +603-2287-0988
Operation Hours  
Monday to Friday 8:00am - 6:00pm 
Saturday 8:00am - 2:00pm
We are closed on Sunday and Public Holidays


Make sure you dont miss interesting happenings by joining our newsletter program.

You are here: Home News Malaysia gains exclusive rights to Japanese cancer treating vaccine